Clinical Trial

Optimization of Radiation Protection Through Genomic Analyses

Study acronym: ORtogether
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The long-term goal is to define "signatures" in the form of genomic changes through sequence analyses of genomic DNA using modern Next Generation Sequencing (NGS) methods, which 1. determine the radiation exposure of humans. 2. provide information about the exposure (dose). 3. determine the radiation quality. 4. predict the repair capacity and radiation resistance of an individual.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-07; most recent amendment 2024-09-25.
Status change: Not Yet Recruiting → Recruiting 2024-09-25
Trial Details
NCT Number NCT06253338
Lead Sponsor University Hospital, Essen
Conditions DNA, Cancer, Radiation
Enrollment 30 participants
Start Date 2024-06-01
Primary Completion 2025-12-15 (estimated)
Study Completion 2030-01-15 (estimated)
Updated on ClinicalTrials.gov 2024-09-27